Recently they argued that this adipokine has to be considered a growth factor in ERα-positive breast cancer cells since adiponectin might impair LKB1/AMPK interaction, inducing a rapid activation of ERα and MAPK [139,140,141] (Figure 3). The gene discussed is ESR1; the disease is breast cancer.